3/25/22, 6:32 PM
Weight loss outcomes with FDA-approved medications - UpToDate
Official reprint from UpToDate®
www.uptodate.com © 2022 UpToDate, Inc. and/or its affiliates. All Rights Reserved.
Weight loss outcomes with FDA-approved medications
Weight loss reflects results at 52 weeks, except for semaglutide and liraglutide, which reflect
weight loss at 68 weeks.
FDA: US Food and Drug Administration.
https://www.uptodate.com/contents/image/print?topicKey=PC%2F5376&view=machineLearning&search=obesity drug therapy&sectionRank=1&usage…
1/2
3/25/22, 6:32 PM
Weight loss outcomes with FDA-approved medications - UpToDate
Courtesy of George A Bray, MD.
Data from:
1. Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss
and adverse events: A systematic review and meta-analysis. JAMA 2016; 315:2424.
2. Rubino DM, Greenway FL, Khalid U, et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body
weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial. JAMA 2022;
327:138.
3. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl
J Med 2021; 384:989.
Graphic 115096 Version 5.0
https://www.uptodate.com/contents/image/print?topicKey=PC%2F5376&view=machineLearning&search=obesity drug therapy&sectionRank=1&usage…
2/2